Background: Recent evidence suggests that both the HIV virus and antiretroviral therapy (ART) are associated with premature atherosclerosis in adults. Increased arterial stiffness as assessed by pulse wave velocity (PWV) has been associated with adverse cardiovascular outcome in adults. The relationship between HIV infection and treatment and arterial stiffness has not been evaluated in children. Methods: We studied 83 HIV-infected children with a mean ±sd age of 11.0 ±3.1 years and 59 controls aged 12.2 ±2.8 years. Among the HIV-infected children, 48 were receiving ART (23 including a protease inhibitor). Arterial stiffness was assessed non-invasively by carotidradial PWV. Disease severity was defined according to the CDC classification. Results: PWV was significantly increased in HIV-infected children compared with controls (P<0.05). A significant association between age and PWV was noted in HIVinfected children but not in controls. HIV-infected children receiving ART had significantly increased total cholesterol levels and PWV compared with non-treated children (P<0.001 and P<0.05, respectively). CDC stage was greater in ART-treated compared with non-treated HIV-infected children (P<0.001). No differences in other cardiovascular risk factors were noted in the two groups. After multivariable analysis, ART, systolic blood pressure, disease severity and total cholesterol remained independent predictors of PWV. Conclusions: HIV-infected children have increased arterial stiffness compared with healthy children. These changes were more pronounced with increasing age in HIV-infected children particularly in those who were receiving ART.
A substantial body of evidence highlights the increased incidence of cardiovascular events in HIVinfected patients [1] . However, the relative contribution of HIV virus, antiretroviral therapy (ART) and that of the classical cardiovascular risk factors commonly overrepresented in this group of patients remains unclear [1] . For instance, experimental studies have shown that viral components might convert the vascular endothelium to a proinflammatory and prothrombotic surface and that the antiretroviral regimens can have an independent detrimental effect on metabolic parameters and endothelial function [2, 3] . Furthermore, we and others have demonstrated endothelial dysfunction and carotid arterial changes in HIV-infected patients as early as the first and second decades of life [4, 5] .
Recent data suggests that pulse wave velocity (PWV), a well described index of arterial stiffness, has a key role in detecting early structural arterial disease progression and is a powerful predictor of cardiovascular outcome in at-risk groups and the general population [6] [7] [8] [9] [10] . This measure integrates information about the interactions between the physical properties of the arterial system, rheological characteristics of the blood and ventricular function [6, 11, 12] . The equipment for measurement of PWV is portable, relatively inexpensive, and the technique is easy to learn and perform accurately. Thus, PWV assessment in the clinical setting is of emerging interest for cardiovascular risk stratification in populations that are likely to be at increased risk for clinical arterial disease.
We therefore set out to measure PWV responses in HIV-infected children and controls in order to explore whether this disease is associated with increased arterial stiffness in early life and to identify its determinants, minimizing the confounding effect of the conventional vascular risk factor burden that usually accumulates by adulthood. 
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Methods
Study population
All children older than 5 years who were attending the outpatient clinic at Great Ormond Street Hospital NHS Trust (London, UK) were invited to participate in the study. The age selection was made to ensure cooperation of the patient during the vascular assessment. The 83 children who were studied had contracted the HIV virus perinatally and their parents agreed for their participation in the study. Children with current opportunistic infections or cardiovascular risk factors including diabetes, hypertension and renal failure were excluded from the study. For comparison, 59 healthy children were recruited as control participants from healthy siblings of the HIVinfected children and children of staff working at the hospital. None had a current or recent infectious illness, nor were receiving any medication or vitamin supplementation.
Cardiovascular risk assessment
Anthropometric measurements Weight and height were measured and body mass index (BMI; kg/m 2 ) was calculated. Because anthropometric measures vary with age the values were converted to age-and sex-adjusted z-scores with the use of European reference curves when available [13] . Blood pressure was measured as the average of three seated readings with an automated oscillometric device (Omron, Kyoto, Japan). A paediatric cuff was used when the arm circumference was <25 cm and an adult cuff when the arm circumference was >25 cm.
Biochemical markers
Non-fasting blood was taken in heparinized tubes and 1 ml of plasma was stored at -80°C. Total cholesterol was assessed by enzymatic colorimetry and high-density lipoprotein (HDL) cholesterol was measured directly in plasma after precipitation with polyethylene glycol (Roche Diagnostics GmbH, Penzberg, Germany). Lipoprotein (a) (Lp[a]) serum levels were measured by immunoturbimetry kits from WAKO Diagnostics (Richmond, VA, USA) and DiaSys Diagnostic Systems GmbH (Holzheim, Germany).
HIV disease activity was assessed by measuring HIV RNA viral load and CD4%. A branched DNA assay (Chiron Diagnostics, Sudbury, Suffolk, UK) was used to assess the former with a lower limit of detection of 50 copies/ml and flow cytometry the latter. High-sensitivity c-reactive protein (hsCRP) was measured by ELISA. The ELISA method has high sensitivity and specificity with a detection rate for hsCRP as low as 0.03 µg/ml and inter-and intraobserver variability ranging from 4% to 5%.
Pulse wave velocity measurements
All children underwent measurement of PWV using the SphygmoCor system (West Ryde Corporate Centre, West Ryde, Australia). The pressure pulse waveform was recorded consecutively in the radial and carotid artery simultaneously with an ECG signal, which provides an R-timing reference. The integral SphygmoCor software processes and then calculates the mean time difference between R-wave and pressure wave on a beat to beat basis. PWV (m/s) is then calculated using the mean time difference and the carotid to radial arterial length. All measurements were performed from the same independent technician who was blinded to the clinical condition of the studied child. The intraobserver variation for PWV measurement is 4% in our unit.
Statistical analyses
Comparisons were made initially between patients and controls and then within the HIV cohort. In descriptive analyses when data were normally distributed, parametric statistics and significance tests were used; otherwise, non-parametric methods were used. Multiple linear regression analysis was used to assess associations between arterial stiffness and other potential confounding factors (that is, the presence or absence of HIV infection, heart rate and mean arterial pressure, age, gender, BMI, lipids, hsCRP and HIV-related factors such as viral load, CD4 + T-cell count and ART). In this study, we calculated that 50 children in each group would allow us to detect a 0.5 m/s difference in PWV with 80% power and at 5% significance level. All reported P-values are based on two-sided tests and compared with a significance level of 5%. SPSS version 12 software (SPSS Inc., Chicago, IL, USA) was used for all statistical calculations.
Results
Study population
The 83 HIV-infected children had a mean ±sd age of 11.0 ±3.1 years and all had acquired HIV from mother-tochild transmission. The control children were aged 12.2 ±2.8 years and had similar age-adjusted BMI z-scores. Comparisons in the clinical parameters between HIVinfected children and controls are depicted in Table 1 .
In the HIV cohort, 48 children were taking ART (23 including a protease inhibitor [PI]) and 35 were not receiving any ART. A total of 20 HIV-infected children had previously experienced a CDC stage C disease and all had been treated with ART [14] . Comparisons in the clinical parameters between ART-treated and -untreated HIV-infected children are shown in Table 2 .
Lipoprotein and inflammatory parameters
HIV-infected children had dyslipidaemia and increased hsCRP compared with controls ( HIV cohort, differences in lipoprotein parameters were noted between those receiving ART and the non-treated HIV-infected children. Total cholesterol was increased and HDL cholesterol decreased in treated HIV-infected children compared with those who were untreated (P<0.001 for both; Table 2 ).
Pulse wave velocity measurements
PWV was increased in HIV-infected children compared with controls (P<0.05; Figure 1 ) in both unadjusted and adjusted analyses. No significant difference was noted between ART-naive children and controls (P=NS). A significant association between PWV and age was noted in the HIV-infected children (r=0.3, P=0.02) but not in controls.
Within the HIV cohort, increased PWV was noted in those children who were receiving ART compared with ART-naive children (P<0.05; Figure 1 ) Within the ART group, PWV in children who were receiving PI in their combination was similar to PWV on children receiving non-PI ART (mean ±sd 7.9 ±0.32 versus 7.7 ±0.31 m/s; P=NS).
In univariate analyses, age (r=0.26, P<0.05), total cholesterol (r=0.29, P<0.01), systolic and diastolic blood pressure (r=0.26, P<0.05 and r=0.34, P<0.01, respectively) and duration of exposure to ART (r=0.28, P<0.05) were associated with PWV. After multivariable regression analysis adjusting for age, sex, blood pressure, heart rate and other classical risk factors, ART, systolic blood pressure, disease severity and total cholesterol remained independent predictors of PWV.
Discussion
In this study, we have demonstrated that HIV-infected children who have perinatally acquired the virus have increased arterial stiffness compared with healthy children. These arterial changes in HIV children were more pronounced with increasing age, which was not observed in controls, indicating an accelerated arteriosclerotic disease process in childhood HIV infection.
In a previous study, we demonstrated that HIVinfected children had evidence of endothelial dysfunction, as assessed by flow-mediated vasodilation, and structural abnormalities measured by carotid intima media thickness. This study confirms the disturbed arterial phenotype in HIV-infected children by assessing another arterial parameter, arterial stiffness, measured by PWV. However, in contrast to the ultrasound-based techniques, the PWV technique is reproducible, easy to use, and portable, and therefore should have greater utility for screening young populations at increased vascular risk in the clinical setting [15] [16] [17] . Commonly used markers of early vascular disease, such as blood pressure and pulse pressure, failed to detect differences between the HIV-infected children and controls. The data from our study and from studies performed in adults suggest that these conventional brachial blood pressure measurements are not likely to be as sensitive as direct measures of arterial stiffness for the detection of subtle early changes in arterial physiology.
Alterations in PWV have been associated with classical cardiovascular risk factors in adults and children, and studies performed in adults have documented that PWV can be used to predict adverse cardiovascular events [6] . Recent studies have also associated HIV infection and ART in adults with increased carotid intima media thickness and increased arterial stiffness [18] [19] [20] . In our cohort we were able to show an association between total cholesterol, blood pressure and PWV, although values for these parameters were within normal ranges for their age. In addition, PWV was increased in relation 
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to the severity of HIV disease and to ART. There was no statistically significant difference in PWV between controls and ART-naive patients. However, the relative contributions of ART and that of the HIV virus to arterial disease cannot be determined using this cross-sectional design. In particular, children who presented with the more severe disease were the first candidates for starting ART at the time of the study in our institution. Further studies are required to explore the role HIV and its therapy on arterial disease in childhood.
In the era of ART, HIV-infected children are surviving much longer and thus it is important to consider the potential for premature cardiovascular morbidity and mortality risk. As it is now possible to slow or even reverse the progression of atherosclerotic vascular disease with a number of safe and effective pharmacological and lifestyle alterations, earlier identification of those at risk and application of appropriate preventive therapeutic strategies are of major importance. This study shows that PWV can be used in the clinic to assess vascular health in HIV-infected children during a stage of life when dietary and therapeutic interventions could reverse and limit arterial injury.
